Increase text sizeDecrease text sizeDefault text size

Discussion Paper: Biologic medicines and biosimilars in the Australian landscape – The challenges and the opportunities

1 August 2016

In Brief: Allens is engaging with stakeholders on the challenges and opportunities presented by biosimilars.

As part of this engagement, we highlight a number of key issues for discussion and comment.

>> Download a PDF copy of the Discussion Paper.

For further information, please contact:

Share or Save for later

What are these?


To save this publication on your smartphone or
tablet for off-line reading (eg on a plane flight),
we recommend Pocket.